| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Article |
Turku PET Centre (K.A.V., P.P., M.A., T.V., T.T., J.K., P.N.), Departments of Radiology (R.P.), Medicine (M.A., T.R., P.N.), Pharmacology and Clinical Pharmacology (R.H.), University of Turku, Turku University Central Hospital, Turku 20521, Finland; and Department of Medicine (P.L.), University of Gothenburg, Gothenburg 41345, Sweden
Address all correspondence and requests for reprints to: Pirjo Nuutila, Turku PET Centre, University of Turku, P.O. Box 52, 20521 Turku, Finland. E-mail: . pirjo.nuutila{at}utu.fi
Abstract
To elucidate the role of adipose tissue glucose uptake in whole-body metabolism, sc and visceral adipose tissue glucose uptake and perfusion were measured in 10 nonobese and 10 age-matched obese men with positron emission tomography using [18F]-2-fluoro-2-deoxy-D-glucose, and [15O]-labeled water during normoglycemic hyperinsulinemia. Whole-body and skeletal muscle glucose uptake rates per kilogram were lower in obese than in nonobese subjects (P < 0.01). Compared with nonobese, the obese subjects had 67% lower abdominal sc and 58% lower visceral adipose tissue glucose uptake per kilogram of fat. In both groups, insulin stimulated glucose uptake per kilogram fat was significantly higher in visceral fat depots than in sc regions (P < 0.01). Both sc and visceral adipose tissue blood flow expressed per kilogram and minute was impaired in the obese subjects, compared with the nonobese (P < 0.05). Fat masses measured with magnetic resonance images were higher in obese than in nonobese individuals. If regional glucose uptake rates were expressed as per total fat mass, total glucose uptake rates per depot were similar in obese and nonobese subjects and represented 4.1% of whole-body glucose uptake in obese and 2.6% in nonobese subjects (P < 0.02 between the groups). In conclusion, insulin-stimulated glucose uptake per kilogram fat is higher in visceral than in sc adipose tissue. Glucose uptake and blood flow in adipose tissue exhibit insulin resistance in obesity, but because of the larger fat mass, adipose tissue does not seem to contribute substantially to the reduced insulin stimulated whole-body glucose uptake in obesity.
This article has been cited by other articles:
![]() |
N. Halberg, T. Khan, M. E. Trujillo, I. Wernstedt-Asterholm, A. D. Attie, S. Sherwani, Z. V. Wang, S. Landskroner-Eiger, S. Dineen, U. J. Magalang, et al. Hypoxia-Inducible Factor 1{alpha} Induces Fibrosis and Insulin Resistance in White Adipose Tissue Mol. Cell. Biol., August 15, 2009; 29(16): 4467 - 4483. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mitrou, E. Boutati, V. Lambadiari, E. Maratou, A. Papakonstantinou, V. Komesidou, L. Sidossis, N. Tountas, N. Katsilambros, T. Economopoulos, et al. Rates of Glucose Uptake in Adipose Tissue and Muscle in Vivo after a Mixed Meal in Women with Morbid Obesity J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 2958 - 2961. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gallagher, D. E Kelley, J.-E. Yim, N. Spence, J. Albu, L. Boxt, F X. Pi-Sunyer, and S. Heshka Adipose tissue distribution is different in type 2 diabetes Am. J. Clinical Nutrition, March 1, 2009; 89(3): 807 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Lindroos, K. Majamaa, A. Tura, A. Mari, K. K. Kalliokoski, M. T. Taittonen, P. Iozzo, and P. Nuutila m.3243A>G Mutation in Mitochondrial DNA Leads to Decreased Insulin Sensitivity in Skeletal Muscle and to Progressive {beta}-Cell Dysfunction Diabetes, March 1, 2009; 58(3): 543 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ferrannini, A. M. Sironi, P. Iozzo, and A. Gastaldelli Intra-abdominal adiposity, abdominal obesity, and cardiometabolic risk Eur. Heart J. Suppl., March 1, 2008; 10(suppl_B): B4 - B10. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. La Colla, A. Albertin, G. La Colla, and A. Mangano Faster wash-out and recovery for desflurane vs sevoflurane in morbidly obese patients when no premedication is used Br. J. Anaesth., September 1, 2007; 99(3): 353 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. McLeod, R. L. Baldwin VI, M. B. Solomon, and R. G. Baumann Influence of ruminal and postruminal carbohydrate infusion on visceral organ mass and adipose tissue accretion in growing beef steers J Anim Sci, September 1, 2007; 85(9): 2256 - 2270. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Baldwin VI, K. R. McLeod, J. P. McNamara, T. H. Elsasser, and R. G. Baumann Influence of abomasal carbohydrates on subcutaneous, omental, and mesenteric adipose lipogenic and lipolytic rates in growing beef steers J Anim Sci, September 1, 2007; 85(9): 2271 - 2282. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hosogai, A. Fukuhara, K. Oshima, Y. Miyata, S. Tanaka, K. Segawa, S. Furukawa, Y. Tochino, R. Komuro, M. Matsuda, et al. Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation Diabetes, April 1, 2007; 56(4): 901 - 911. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Albertin, D. Poli, L. La Colla, M. Gonfalini, S. Turi, N. Pasculli, G. La Colla, P. C. Bergonzi, E. Dedola, and I. Fermo Predictive performance of 'Servin's formula' during BIS(R)-guided propofol-remifentanil target-controlled infusion in morbidly obese patients Br. J. Anaesth., January 1, 2007; 98(1): 66 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Iozzo, A. Gastaldelli, M. J. Jarvisalo, J. Kiss, R. Borra, E. Buzzigoli, A. Viljanen, G. Naum, T. Viljanen, V. Oikonen, et al. 18F-FDG Assessment of Glucose Disposal and Production Rates During Fasting and Insulin Stimulation: A Validation Study J. Nucl. Med., June 1, 2006; 47(6): 1016 - 1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Summers Adipose tissue metabolism, diabetes and vascular disease -- lessons from in vivo studies Diabetes and Vascular Disease Research, May 1, 2006; 3(1): 12 - 21. [Abstract] [PDF] |
||||
![]() |
L. Laviola, S. Perrini, A. Cignarelli, A. Natalicchio, A. Leonardini, F. De Stefano, M. Cuscito, M. De Fazio, V. Memeo, V. Neri, et al. Insulin signaling in human visceral and subcutaneous adipose tissue in vivo. Diabetes, April 1, 2006; 55(4): 952 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hadigan, D. Kamin, J. Liebau, S. Mazza, S. Barrow, M. Torriani, R. Rubin, S. Weise, A. Fischman, and S. Grinspoon Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E289 - E298. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. M. Viljanen, K. A. Virtanen, M. J. Jarvisalo, K. Hallsten, R. Parkkola, T. Ronnemaa, F. Lonnqvist, P. Iozzo, E. Ferrannini, and P. Nuutila Rosiglitazone Treatment Increases Subcutaneous Adipose Tissue Glucose Uptake in Parallel with Perfusion in Patients with Type 2 Diabetes: A Double-Blind, Randomized Study with Metformin J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6523 - 6528. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Virtanen, P. Iozzo, K. Hallsten, R. Huupponen, R. Parkkola, T. Janatuinen, F. Lonnqvist, T. Viljanen, T. Ronnemaa, P. Lonnroth, et al. Increased Fat Mass Compensates for Insulin Resistance in Abdominal Obesity and Type 2 Diabetes: A Positron-Emitting Tomography Study Diabetes, September 1, 2005; 54(9): 2720 - 2726. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vanttinen, P. Nuutila, J. Pihlajamaki, K. Hallsten, K. A. Virtanen, R. Lautamaki, P. Peltoniemi, J. Kemppainen, T. Takala, A. P. M. Viljanen, et al. The Effect of the Ala12 Allele of the Peroxisome Proliferator-Activated Receptor-{gamma}2 Gene on Skeletal Muscle Glucose Uptake Depends on Obesity: A Positron Emission Tomography Study J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4249 - 4254. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lundgren, J. Buren, T. Ruge, T. Myrnas, and J. W. Eriksson Glucocorticoids Down-Regulate Glucose Uptake Capacity and Insulin-Signaling Proteins in Omental But Not Subcutaneous Human Adipocytes J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2989 - 2997. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tanoli, P. Yue, D. Yablonskiy, and G. Schonfeld Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity J. Lipid Res., May 1, 2004; 45(5): 941 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. El-Haschimi, S. D. Dufresne, M. F. Hirshman, J. S. Flier, L. J. Goodyear, and C. Bjorbaek Insulin Resistance and Lipodystrophy in Mice Lacking Ribosomal S6 Kinase 2 Diabetes, June 1, 2003; 52(6): 1340 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
Time2Take on risk -- making the link between insulin resistance and cardiovascular risk: Report of a GSK symposium from Diabetes UK, Glasgow, March 19th 2003 The British Journal of Diabetes & Vascular Disease, March 1, 2003; 3(2_suppl): S1 - S8. [PDF] |
||||
![]() |
K. A. Virtanen, K. Hallsten, R. Parkkola, T. Janatuinen, F. Lonnqvist, T. Viljanen, T. Ronnemaa, J. Knuuti, R. Huupponen, P. Lonnroth, et al. Differential Effects of Rosiglitazone and Metformin on Adipose Tissue Distribution and Glucose Uptake in Type 2 Diabetic Subjects Diabetes, February 1, 2003; 52(2): 283 - 290. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |